References
- Purandare N, Oude-Voshaar RC, Burns A, Velupandian UM, McCollum C. Paradoxical embolization: a potential cause of cerebral damage in Alzheimer's disease? Neurol Res. 2006;28:679–84.
- Purandare N, Oude-Voshaar RC, Burns A, Velupandian UM, McCollum C. Paradoxical embolisation and cerebral white matter lesions in Dementia. Br J Radiol. 2008;81:30–4.
- Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al.. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019–27.
- Adair JC. Dementia associated with antiphospholipid antibodies. Rheumatology. 2006;45:241–2.
- Chapman J, Abu-Katash M, Inzelberg R, Yust I, Neufeld MY, Vardinon N, et al.. Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants. J Neurol Sci. 2002;203–204: 81–4.
- Gómez-Puerta JA, Cervera R, Calvo LM, Gómez-Ansón B, Espinosa G, Claver G, et al.. Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients. Rheumatology. 2005;44:95–9.
- Tektonidou MG, Varsou N, Kotoulas G, Antoniou A, Moutsopoulos HM. Cognitive deficits in patients With antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch Intern Med. 2006;20:2278–84.
- Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera RS, et al.. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (Aps). J Thromb Haemost. 2006;4:295–306.
- Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, et al.. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 2009;73:1738–45.
- Salgado JV, Malloy-Diniz LF, Abrantes SS, Moreira L, Schlottfeldt CG, Guimarães W, et al.. Applicability of the Rey auditory-verbal learning test to an adult sample in Brazil. Rev Bras Psiquiatr. 2011;33:234–7.
- Strauss E, Sherman EMS, Spreen O. A compendium of neuropsychological tests: administration, norms, and commentary. 2nd ed. New York: Oxford University Press, 1998.
- Ajaj A, Luhishi E, Metaraiah E. Primary antiphospholipid syndrome unusual presentation in a seventy two year old man. Libyan J Med. 2008;3:106–7.
- Denburg SD, Carbotte RM, Ginsberg JS, Denburg JA. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc. 1997;3:377–86.
- Menon S, Jameson-Shortall E, Newman SP, Hall-Graggs MR, Chinn R, Isenberg DA. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum. 1999;42:735–41.
- Hanly JG, Hong C, Smith S, Fisk J. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum. 1999;42:728–34.
- Jesus PAP, Vieira-de-Melo RM. Cognitive dysfunction incongestive heart failure: Transcranial Doppler evidence of microembolic etiology. Arq Neuropsiquiatr. 2006;64:207–10.
- Diniz BS, Teixeira AL. Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond. Neuromolecular Med. 2011;13(4):217–22.
- Greenberg Xu B, Lu B, Hempstead BL. New insights in the biology of BDNF synthesis and release: implications in CNS function. J Neurosci. 2009;29:12764–7.
- Lu CS, Horizon AA, Hwang KK, FitzGerald J, Lin WS, Hahn BH, et al.. Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome. Arthritis Rheum. 2005;52:4018–27.
- Schmidt R, Auer-Grumbach P, Fazekas F, Offenbacher H, Kape P. Anticardiolipin antibodies in normal subjects: neuropsychological correlates and MRI findings. Stroke. 1995;26:749–54.
- De Groot JC, De Leeuw FE, Oudkerk M, Van Gijn J, Hofman A, Jolles J, et al.. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol. 2002;52:335–41.
- Roman GC. Vascular dementia prevention: a risk factor analysis. Cerebrovasc Dis. 2005;20:91–100.
- Stimmler MM, Coletti PM, Quismorio FP. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum. 1993;22:335–49.